Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 785934, 7 pages
http://dx.doi.org/10.1155/2010/785934
Clinical Study

Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer

1Service d'Oncologie, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75012 Paris, France
2Groupe Hospitalier Pitié Salpétrière, Service d'Hépato-Gastroentérologie, Paris, France
3Centre Paul Papin, Angers, France
4Hôpital Claude-Huriez, Lille, France
5Hôpital Foch, Suresnes, France
6Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France
7Eli Lilly, France

Received 29 July 2009; Accepted 8 February 2010

Academic Editor: Stefano Cascinu

Copyright © 2010 C. Louvet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

C. Louvet, T. André, E. Gamelin, et al., “Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer,” Journal of Oncology, vol. 2010, Article ID 785934, 7 pages, 2010. https://doi.org/10.1155/2010/785934.